Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Research Report 2023

Report ID: 1970032 | Published Date: Jan 2025 | No. of Page: 82 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 BP-101
        1.2.3 Bremelanotide
        1.2.4 Gepirone Hydrochloride ER
        1.2.5 PVT-011
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Out-Patient
        1.3.3 In-Patient
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Perspective (2017-2028)
    2.2 Female Hypoactive Sexual Desire Disorder Therapeutics Growth Trends by Region
        2.2.1 Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Female Hypoactive Sexual Desire Disorder Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Female Hypoactive Sexual Desire Disorder Therapeutics Market Dynamics
        2.3.1 Female Hypoactive Sexual Desire Disorder Therapeutics Industry Trends
        2.3.2 Female Hypoactive Sexual Desire Disorder Therapeutics Market Drivers
        2.3.3 Female Hypoactive Sexual Desire Disorder Therapeutics Market Challenges
        2.3.4 Female Hypoactive Sexual Desire Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Revenue
        3.1.1 Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue
    3.4 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Concentration Ratio
        3.4.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue in 2021
    3.5 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players Head office and Area Served
    3.6 Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Product Solution and Service
    3.7 Date of Enter into Female Hypoactive Sexual Desire Disorder Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Female Hypoactive Sexual Desire Disorder Therapeutics Breakdown Data by Type
    4.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Type (2023-2028)
5 Female Hypoactive Sexual Desire Disorder Therapeutics Breakdown Data by Application
    5.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2017-2028)
    6.2 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2017-2022)
    6.3 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2017-2028)
    7.2 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2017-2028)
    9.2 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Emotional Brain BV
        11.1.1 Emotional Brain BV Company Detail
        11.1.2 Emotional Brain BV Business Overview
        11.1.3 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
        11.1.4 Emotional Brain BV Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022)
        11.1.5 Emotional Brain BV Recent Development
    11.2 GlaxoSmithKline Plc
        11.2.1 GlaxoSmithKline Plc Company Detail
        11.2.2 GlaxoSmithKline Plc Business Overview
        11.2.3 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
        11.2.4 GlaxoSmithKline Plc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022)
        11.2.5 GlaxoSmithKline Plc Recent Development
    11.3 Palatin Technologies Inc
        11.3.1 Palatin Technologies Inc Company Detail
        11.3.2 Palatin Technologies Inc Business Overview
        11.3.3 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
        11.3.4 Palatin Technologies Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022)
        11.3.5 Palatin Technologies Inc Recent Development
    11.4 Pivot Pharmaceuticals Inc
        11.4.1 Pivot Pharmaceuticals Inc Company Detail
        11.4.2 Pivot Pharmaceuticals Inc Business Overview
        11.4.3 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
        11.4.4 Pivot Pharmaceuticals Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022)
        11.4.5 Pivot Pharmaceuticals Inc Recent Development
    11.5 Strategic Science & Technologies LLC
        11.5.1 Strategic Science & Technologies LLC Company Detail
        11.5.2 Strategic Science & Technologies LLC Business Overview
        11.5.3 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
        11.5.4 Strategic Science & Technologies LLC Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022)
        11.5.5 Strategic Science & Technologies LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of BP-101
    Table 3. Key Players of Bremelanotide
    Table 4. Key Players of Gepirone Hydrochloride ER
    Table 5. Key Players of PVT-011
    Table 6. Key Players of Others
    Table 7. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Region (2017-2022)
    Table 11. Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Region (2023-2028)
    Table 13. Female Hypoactive Sexual Desire Disorder Therapeutics Market Trends
    Table 14. Female Hypoactive Sexual Desire Disorder Therapeutics Market Drivers
    Table 15. Female Hypoactive Sexual Desire Disorder Therapeutics Market Challenges
    Table 16. Female Hypoactive Sexual Desire Disorder Therapeutics Market Restraints
    Table 17. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Players (2017-2022)
    Table 19. Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics as of 2021)
    Table 20. Ranking of Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Product Solution and Service
    Table 24. Date of Enter into Female Hypoactive Sexual Desire Disorder Therapeutics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Type (2017-2022)
    Table 28. Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Type (2023-2028)
    Table 30. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Application (2017-2022)
    Table 32. Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Application (2023-2028)
    Table 34. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Emotional Brain BV Company Detail
    Table 45. Emotional Brain BV Business Overview
    Table 46. Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Product
    Table 47. Emotional Brain BV Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 48. Emotional Brain BV Recent Development
    Table 49. GlaxoSmithKline Plc Company Detail
    Table 50. GlaxoSmithKline Plc Business Overview
    Table 51. GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Product
    Table 52. GlaxoSmithKline Plc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 53. GlaxoSmithKline Plc Recent Development
    Table 54. Palatin Technologies Inc Company Detail
    Table 55. Palatin Technologies Inc Business Overview
    Table 56. Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product
    Table 57. Palatin Technologies Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 58. Palatin Technologies Inc Recent Development
    Table 59. Pivot Pharmaceuticals Inc Company Detail
    Table 60. Pivot Pharmaceuticals Inc Business Overview
    Table 61. Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product
    Table 62. Pivot Pharmaceuticals Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 63. Pivot Pharmaceuticals Inc Recent Development
    Table 64. Strategic Science & Technologies LLC Company Detail
    Table 65. Strategic Science & Technologies LLC Business Overview
    Table 66. Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Product
    Table 67. Strategic Science & Technologies LLC Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 68. Strategic Science & Technologies LLC Recent Development
    Table 69. Research Programs/Design for This Report
    Table 70. Key Data Information from Secondary Sources
    Table 71. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. BP-101 Features
    Figure 3. Bremelanotide Features
    Figure 4. Gepirone Hydrochloride ER Features
    Figure 5. PVT-011 Features
    Figure 6. Others Features
    Figure 7. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application in 2021 & 2028
    Figure 8. Out-Patient Case Studies
    Figure 9. In-Patient Case Studies
    Figure 10. Female Hypoactive Sexual Desire Disorder Therapeutics Report Years Considered
    Figure 11. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Region: 2021 VS 2028
    Figure 14. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Players in 2021
    Figure 15. Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue in 2021
    Figure 17. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Country (2017-2028)
    Figure 19. United States Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Country (2017-2028)
    Figure 23. Germany Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Region (2017-2028)
    Figure 31. China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Country (2017-2028)
    Figure 39. Mexico Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Country (2017-2028)
    Figure 43. Turkey Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Emotional Brain BV Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022)
    Figure 46. GlaxoSmithKline Plc Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022)
    Figure 47. Palatin Technologies Inc Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022)
    Figure 48. Pivot Pharmaceuticals Inc Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022)
    Figure 49. Strategic Science & Technologies LLC Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2017-2022)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Emotional Brain BV
GlaxoSmithKline Plc
Palatin Technologies Inc
Pivot Pharmaceuticals Inc
Strategic Science & Technologies LLC
Frequently Asked Questions
Female Hypoactive Sexual Desire Disorder Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Female Hypoactive Sexual Desire Disorder Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Female Hypoactive Sexual Desire Disorder Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Alpha Synuclein

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Microtome Cryostat

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More